North Carolina Novo Nordisk’s GLP-1 Pill Makes Key Progress Oct 21, 2025 Novo Nordisk's pill, oral semaglutide, has scored approval for slashing cardiovascular risks, further confirming its health benefits beyond diabetes treatment.